DCF valuation of Novo Nordisk
Novo Nordisk Revenue Growth (5 year) 9.50% year 0 1 2 3 4 5 growth rate 0.095 0.095 0.095 0.095 0.095 revenue 113020.00 123756.90 135513.81 148387.62 162484.44 177920.46 operatingmargin 0.40 0.40 0.40 0.40 0.40 0.40 operating income (EBIT) 45208.00 49502.76 54205.52 59355.05 64993.78 71168.19 tax rate 0.23 0.23 0.23 0.23 0.23 0.23 tax adjusted EBIT 34810.16 38117.13 41738.25 45703.39 50045.21 54799.50 "+Depreciation and Amortization" 3277.00 3588.32 3929.20 4302.48 4711.21 5158.78